Bionano Genomics Stock Price on October 11, 2020

BNGO Stock  USD 0.79  0.03  3.95%   
Below is the normalized historical share price chart for Bionano Genomics extending back to September 21, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bionano Genomics stands at 0.79, as last reported on the 24th of April, with the highest price reaching 0.81 and the lowest price hitting 0.77 during the day.
IPO Date
21st of August 2018
200 Day MA
2.2863
50 Day MA
1.0832
Beta
2.372
 
Covid
If you're considering investing in Bionano Stock, it is important to understand the factors that can impact its price. Bionano Genomics secures Sharpe Ratio (or Efficiency) of -0.17, which signifies that the company had a -0.17% return per unit of risk over the last 3 months. Bionano Genomics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bionano Genomics' Standard Deviation of 3.84, mean deviation of 2.96, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide.
  
At this time, Bionano Genomics' Common Stock Total Equity is very stable compared to the past year. As of the 24th of April 2024, Common Stock Shares Outstanding is likely to grow to about 35.9 M, while Total Stockholder Equity is likely to drop about 89.9 M. . As of the 24th of April 2024, Price To Sales Ratio is likely to drop to 1.70. In addition to that, Price Earnings Ratio is likely to drop to -0.29. Bionano Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1698

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBNGO

Estimated Market Risk

 3.84
  actual daily
33
67% of assets are more volatile

Expected Return

 -0.65
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.17
  actual daily
0
Most of other assets perform better
Based on monthly moving average Bionano Genomics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bionano Genomics by adding Bionano Genomics to a well-diversified portfolio.
Price Book
0.6225
Enterprise Value Ebitda
(0.18)
Price Sales
1.6572
Shares Float
54.5 M
Wall Street Target Price
6.67

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Bionano Genomics Stock history

Bionano Genomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bionano is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bionano Genomics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bionano Genomics stock prices may prove useful in developing a viable investing in Bionano Genomics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding34.1 M35.9 M
Net Loss-119.3 M-113.4 M

Bionano Genomics Stock Technical Analysis

Bionano Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bionano Genomics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bionano Genomics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Bionano Genomics Period Price Range

Bionano Genomics April 24, 2024 Market Strength

Market strength indicators help investors to evaluate how Bionano Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bionano Genomics shares will generate the highest return on investment. By undertsting and applying Bionano Genomics stock market strength indicators, traders can identify Bionano Genomics entry and exit signals to maximize returns

Bionano Genomics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Bionano Genomics' price direction in advance. Along with the technical and fundamental analysis of Bionano Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bionano to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Bionano Genomics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bionano Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bionano Genomics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bionano Genomics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionano Genomics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.
Note that the Bionano Genomics information on this page should be used as a complementary analysis to other Bionano Genomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Bionano Stock analysis

When running Bionano Genomics' price analysis, check to measure Bionano Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionano Genomics is operating at the current time. Most of Bionano Genomics' value examination focuses on studying past and present price action to predict the probability of Bionano Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionano Genomics' price. Additionally, you may evaluate how the addition of Bionano Genomics to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is Bionano Genomics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.81)
Revenue Per Share
1.058
Quarterly Revenue Growth
0.305
Return On Assets
(0.33)
Return On Equity
(1.35)
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.